Lundbeck
HLUN-B.CO
#2511
Rank
ยฃ4.55 B
Marketcap
ยฃ4.76
Share price
-0.93%
Change (1 day)
15.41%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Lundbeck (HLUN-B.CO) - Total debt

Total debt on the balance sheet as of June 2024 : ยฃ0.46 Billion

According to Lundbeck 's latest financial reports the company's total debt is ยฃ0.46 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Lundbeck - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-12-31ยฃ0.48 B-27.34%
2022-12-31ยฃ0.66 B10.63%
2021-12-31ยฃ0.60 B-37.26%
2020-12-31ยฃ0.95 B-12.63%
2019-12-31ยฃ1.09 B
2018-12-31N/A-100%
2017-12-31ยฃ6.79 M-96.87%
2016-12-31ยฃ0.21 B-41.64%
2015-12-31ยฃ0.37 B6.31%
2014-12-31ยฃ0.35 B44.65%
2013-12-31ยฃ0.24 B15.76%
2012-12-31ยฃ0.20 B-2.68%
2011-12-31ยฃ0.21 B-3.55%
2010-12-31ยฃ0.22 B-46.06%
2009-12-31ยฃ0.41 B69.57%
2008-12-31ยฃ0.24 B32.88%
2007-12-31ยฃ0.18 B41.54%
2006-12-31ยฃ0.12 B267.99%
2005-12-31ยฃ35.24 M-9.4%
2004-12-31ยฃ38.9 M